United Arab Emirates · Delayed Price · Currency is AED Pure Health Holding PJSC Statistics
Total Valuation
ADX:PUREHEALTH has a market cap or net worth of AED 26.00 billion. The enterprise value is 42.20 billion.
| Market Cap | 26.00B |
| Enterprise Value | 42.20B |
Important Dates
The last earnings date was Friday, July 31, 2026.
| Earnings Date | Jul 31, 2026 |
| Ex-Dividend Date | Apr 10, 2026 |
Share Statistics
ADX:PUREHEALTH has 11.11 billion shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 11.11B |
| Shares Outstanding | 11.11B |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 0.23% |
| Owned by Institutions (%) | 0.20% |
| Float | 2.48B |
Valuation Ratios
The trailing PE ratio is 12.07 and the forward PE ratio is 11.95. ADX:PUREHEALTH's PEG ratio is 0.90.
| PE Ratio | 12.07 |
| Forward PE | 11.95 |
| PS Ratio | 0.91 |
| PB Ratio | 1.20 |
| P/TBV Ratio | 4.00 |
| P/FCF Ratio | 9.37 |
| P/OCF Ratio | 6.71 |
| PEG Ratio | 0.90 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.65, with an EV/FCF ratio of 15.20.
| EV / Earnings | 19.58 |
| EV / Sales | 1.48 |
| EV / EBITDA | 8.65 |
| EV / EBIT | 14.20 |
| EV / FCF | 15.20 |
Financial Position
The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.83.
| Current Ratio | 1.28 |
| Quick Ratio | 1.06 |
| Debt / Equity | 0.83 |
| Debt / EBITDA | 3.70 |
| Debt / FCF | 6.50 |
| Interest Coverage | 3.20 |
Financial Efficiency
Return on equity (ROE) is 10.57% and return on invested capital (ROIC) is 8.01%.
| Return on Equity (ROE) | 10.57% |
| Return on Assets (ROA) | 3.46% |
| Return on Invested Capital (ROIC) | 8.01% |
| Return on Capital Employed (ROCE) | 7.15% |
| Weighted Average Cost of Capital (WACC) | 6.67% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.53 |
| Inventory Turnover | 15.44 |
Taxes
In the past 12 months, ADX:PUREHEALTH has paid 242.81 million in taxes.
| Income Tax | 242.81M |
| Effective Tax Rate | 9.83% |
Stock Price Statistics
The stock price has decreased by -21.21% in the last 52 weeks. The beta is 0.69, so ADX:PUREHEALTH's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | -21.21% |
| 50-Day Moving Average | 2.25 |
| 200-Day Moving Average | 2.41 |
| Relative Strength Index (RSI) | 60.80 |
| Average Volume (20 Days) | 2,139,705 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ADX:PUREHEALTH had revenue of AED 28.59 billion and earned 2.15 billion in profits. Earnings per share was 0.19.
| Revenue | 28.59B |
| Gross Profit | 7.04B |
| Operating Income | 2.97B |
| Pretax Income | 2.47B |
| Net Income | 2.15B |
| EBITDA | 3.94B |
| EBIT | 2.97B |
| Earnings Per Share (EPS) | 0.19 |
Balance Sheet
The company has 4.73 billion in cash and 18.03 billion in debt, with a net cash position of -13.30 billion or -1.20 per share.
| Cash & Cash Equivalents | 4.73B |
| Total Debt | 18.03B |
| Net Cash | -13.30B |
| Net Cash Per Share | -1.20 |
| Equity (Book Value) | 21.68B |
| Book Value Per Share | 1.69 |
| Working Capital | 4.31B |
Cash Flow
In the last 12 months, operating cash flow was 3.88 billion and capital expenditures -1.10 billion, giving a free cash flow of 2.78 billion.
| Operating Cash Flow | 3.88B |
| Capital Expenditures | -1.10B |
| Depreciation & Amortization | 964.32M |
| Net Borrowing | -801.55M |
| Free Cash Flow | 2.78B |
| FCF Per Share | 0.25 |
Margins
Gross margin is 24.64%, with operating and profit margins of 10.39% and 7.54%.
| Gross Margin | 24.64% |
| Operating Margin | 10.39% |
| Pretax Margin | 8.64% |
| Profit Margin | 7.54% |
| EBITDA Margin | 13.76% |
| EBIT Margin | 10.39% |
| FCF Margin | 9.71% |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 2.33%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 2.33% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 14.27% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 2.33% |
| Earnings Yield | 8.29% |
| FCF Yield | 10.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for ADX:PUREHEALTH is 3.64, which is 55.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 3.64 |
| Price Target Difference | 55.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 9.23% |
| EPS Growth Forecast (3Y) | 13.19% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ADX:PUREHEALTH has an Altman Z-Score of 1.39 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.39 |
| Piotroski F-Score | 4 |